4 unchanged sentences
Amended and Restated Bylaws of Homology Medicines, Inc.
−Removed: Amended and Restated Investors’ Rights Agreement, dated July 28, 2017, by and among Homology Medicines, Inc.
−Removed: and the investors named therein, as amended by Amendment No.
−Removed: 1 Amended and Restated Investors’ Rights Agreement, dated November 6, 2020.
−Removed: Second Amendment to Collaboration and License Agreement, dated October 30, 2020, between Homology Medicines, Inc.
−Removed: and Novartis Institutes for BioMedical Research, Inc.
−Removed: Stock Purchase Agreement, dated November 9, 2020, by and between Homology Medicines, Inc.
−Removed: and Pfizer Inc.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
HOMOLOGY MEDICINES, INC.
−Removed: November 9, 2020
/s/ Arthur O.
3 unchanged sentences
(principal executive officer)
−Removed: November 9, 2020
/s/ Bradford Smith
Bradford Smith
−Removed: Chief Financial Officer, Treasurer and Secretary
+Added: Chief Financial Officer and Treasurer
(principal financial officer and principal accounting officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.